The Global Burden of Disease (GBD) study The Global Burden of Disease (GBD) study examined the impact of 107 major diseases examined the impact of 107 major diseases in a comparative framework including both in a comparative framework including both mortality and disability. When 'disability' mortality and disability. When 'disability' was taken into account, the formerly unwas taken into account, the formerly unrecognised burden of mental disorders recognised burden of mental disorders became undeniably evident. Mental disbecame undeniably evident. Mental disorders ranked as high as cardiovascular orders ranked as high as cardiovascular and respiratory diseases, surpassing all and respiratory diseases, surpassing all cancers combined and even HIV infection. cancers combined and even HIV infection. Depressive disorders, as a single diagnostic Depressive disorders, as a single diagnostic category, were the leading cause of discategory, were the leading cause of disability worldwide. These results have ability worldwide. These results have provided the most powerful scientific supprovided the most powerful scientific support and advocacy for mental health care, port and advocacy for mental health care, because they highlighted loss of human probecause they highlighted loss of human productivity due to mental disorders (Ustun, ductivity due to mental disorders (Ü stü n, 1999). 1999) .
From a scientific point of view, the GBD From a scientific point of view, the GBD study is a 'meta-synthesis' of epidemiostudy is a 'meta-synthesis' of epidemiological information concerning incidence, logical information concerning incidence, prevalence, duration, severity, associated prevalence, duration, severity, associated disability, age of onset, course and treatdisability, age of onset, course and treatment rates of major diseases as well as ment rates of major diseases as well as mortality due to these conditions. These mortality due to these conditions. These epidemiological indicators are built into an epidemiological indicators are built into an internally consistent model of the disease, internally consistent model of the disease, adjusting for disability (i.e. health levels) adjusting for disability (i.e. health levels) throughout the life span. In calculating the throughout the life span. In calculating the burden of disease, 'duration' is a key driver burden of disease, 'duration' is a key driver -like the length of mortgage that drives -like the length of mortgage that drives your monthly payments. We therefore need your monthly payments. We therefore need to study duration in terms of onset, length to study duration in terms of onset, length and end of an episode with stopwatch preciand end of an episode with stopwatch precision, and determine the distribution of each sion, and determine the distribution of each element in the general population. element in the general population. Eaton et al et al (1997) showed in the 12-year (1997) showed in the 12-year follow-up of the Baltimore Epidemiologic follow-up of the Baltimore Epidemiologic Catchment Area (ECA) study that the Catchment Area (ECA) study that the median duration of episodes was 12 weeks median duration of episodes was 12 weeks and the mean duration was 27 weeks for and the mean duration was 27 weeks for both genders (males 26, female 27 weeks) both genders (males 26, female 27 weeks) and that 22% remained chronically ill. and that 22% remained chronically ill. Eaton Eaton et al et al's data were obtained using an 's data were obtained using an additional Life Chart Interview (LCI) with additional Life Chart Interview (LCI) with cognitive anchors, which indicated the cognitive anchors, which indicated the psychopathology across the life span. psychopathology across the life span. Although this method yields the best inforAlthough this method yields the best information available, the 12-year lag may mation available, the 12-year lag may create attrition and discordance between create attrition and discordance between the two sets of evaluation at year 1 and year the two sets of evaluation at year 1 and year 12 (e.g. owing to state-dependent recall 12 (e.g. owing to state-dependent recall bias). Spijker and colleagues also used the bias). Spijker and colleagues also used the LCI retrospectively on a prospective sample LCI retrospectively on a prospective sample assessed by the Composite International assessed by the Composite International Diagnostic Interview (CIDI), but over a Diagnostic Interview (CIDI), but over a 2-year period. 2-year period.
SCIENTIFIC STUDIES SCIENTIFIC STUDIES OF DUR ATION OF DUR ATION
The National Comorbidity Survey The National Comorbidity Survey (NCS) did not include a longitudinal (NCS) did not include a longitudinal follow-up of cases identified in the comfollow-up of cases identified in the community, but the diagnostic interview munity, but the diagnostic interview included questions related to the duration included questions related to the duration of lifetime episodes of depression (Kessler of lifetime episodes of depression (Kessler et al et al, 1994) . For the purpose of this analy-, 1994). For the purpose of this analysis, 3% of the participants who had had sis, 3% of the participants who had had very long episodes were excluded. For the very long episodes were excluded. For the remaining 97% of the sample with episodes remaining 97% of the sample with episodes of depression, the overall mean duration of depression, the overall mean duration was 22.6 weeks (further details available was 22.6 weeks (further details available from the author upon request). Kendler from the author upon request). , however, found that the mean (1997), however, found that the mean time to recovery in 235 women was 13 time to recovery in 235 women was 13 weeks. weeks.
So we now have 'duration' data from a So we now have 'duration' data from a handful of studies to incorporate in the handful of studies to incorporate in the new wave of GBD calculations, which new wave of GBD calculations, which was not the case when the original GBD was not the case when the original GBD study was done: mean durations of 27 study was done: mean durations of 27 weeks (Eaton weeks (Eaton et al et al, 1997) 's study (6 weeks). The results pro-(6 weeks). The results provide input to create better models of the vide input to create better models of the burden of depressive disorders, enabling burden of depressive disorders, enabling us to tease out duration, severity and age us to tease out duration, severity and age at onset. The GBD 1996 results were at onset. The GBD 1996 results were generally accepted, but calculations for generally accepted, but calculations for depressive disorders remained debatable: depressive disorders remained debatable: episode incidence was modelled for women episode incidence was modelled for women as 0.29% and for men 0.16%; episode as 0.29% and for men 0.16%; episode average age at onset was 37.1 years, with average age at onset was 37.1 years, with an average episode duration of 6 months an average episode duration of 6 months (Murray & Lopez, 1996: pp. 601-606) . (Murray & Lopez, 1996: pp. 601-606) . How plausible are these estimates? How plausible are these estimates?
The GBD incidence and prevalence estiThe GBD incidence and prevalence estimates for depressive episodes are low in mates for depressive episodes are low in comparison with modern psychiatric epidecomparison with modern psychiatric epidemiological findings: the annual prevalence miological findings: the annual prevalence of unipolar depression was 12.9% for of unipolar depression was 12.9% for women in the NCS (Kessler women in the NCS (Kessler et al et al, 1994 (Kessler et al et al, ), , 1994 ), compared with the 1.7% prevalence esticompared with the 1.7% prevalence estimate used in the GBD calculations. Simimate used in the GBD calculations. Similarly, the age of onset of 37.1 years is far larly, the age of onset of 37.1 years is far beyond the common finding of 20-25 years beyond the common finding of 20-25 years (Burke (Burke et al et al, 1991) . Finally, the duration , 1991). Finally, the duration figure of 6 months was based mainly on figure of 6 months was based mainly on clinical textbook knowledge. In the absence clinical textbook knowledge. In the absence of epidemiological data, Kraepelin's clinical of epidemiological data, Kraepelin's clinical hunch was 6-8 months on average episodes hunch was 6-8 months on average episodes lasting between 8 days and several years lasting between 8 days and several years . Clinical impressions are . Clinical impressions are known to include chronic duration as a known to include chronic duration as a requirement (Rousseau, 2000) . Clinical requirement (Rousseau, 2000) . Clinical cases are also presumed to be more severe cases are also presumed to be more severe and longer-lasting than community cases and longer-lasting than community cases (Costello, 1990) , which is possibly due to (Costello, 1990) , which is possibly due to the filtering effect the filtering effect of care-seeking and of care-seeking and severity. Indeed, in severity. Indeed, in the World Health the World Health Organization (WHO) Primary Care study Organization (WHO) Primary Care study we found that among the primary care we found that among the primary care attenders with depression 33.5% were still attenders with depression 33.5% were still depressed at the end of a year and first depressed at the end of a year and first episodes lasted longer (Ustun & Sartorius, episodes lasted longer (Ü stü n & Sartorius, 1995; also further details available from 1995; also further details available from the author upon request). the author upon request). These discrepancies between the newly These discrepancies between the newly available epidemiological evidence and the available epidemiological evidence and the GBD modelling are noteworthy for future GBD modelling are noteworthy for future research and the next wave of GBD calcularesearch and the next wave of GBD calculations. The GBD approach logically assumes tions. The GBD approach logically assumes a linear relation between incidence, duraa linear relation between incidence, duration and prevalence. The modelling was, tion and prevalence. The modelling was, however, done with average duration and however, done with average duration and single (uniform) severity for all depressive single (uniform) severity for all depressive episodes. The good news is that it is now episodes. The good news is that it is now possible to do more detailed modelling with possible to do more detailed modelling with the data from these empirical studies, inthe data from these empirical studies, including depression severity, duration and cluding depression severity, duration and access to care, as Spijker access to care, as Spijker et al et al have teased have teased out. It may also be possible to extend these out. It may also be possible to extend these studies to young adults and children to studies to young adults and children to explore these parameters in earlier life explore these parameters in earlier life (e.g. , for exam-(e.g. , for example 'college depression' is usually moderate ple 'college depression' is usually moderate and of short duration, mainly associated and of short duration, mainly associated with social adjustment and grades (Oswalt with social adjustment and grades (Oswalt & Finkelberg, 1995 ). & Finkelberg, 1995 .
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FUTURE RESEARCH FUTURE RESEARCH RECOMMENDATIONS RECOMMENDATIONS
In epidemiological modelling, the devil is In epidemiological modelling, the devil is always in the methodological detail. always in the methodological detail.
(a) (a) Mental health epidemiology has largely
Mental health epidemiology has largely relied on 'lifetime' prevalence estimates. relied on 'lifetime' prevalence estimates. Lifetime prevalence is not used in other Lifetime prevalence is not used in other speciality areas, and hence is not useful speciality areas, and hence is not useful for making comparisons between for making comparisons between mental health and other fields. The mental health and other fields. The GBD study used 1-month prevalence GBD study used 1-month prevalence rates, which took into account the rates, which took into account the 'duration criteria' built into the diag-'duration criteria' built into the diagnostic definition of mental disorders. nostic definition of mental disorders. It will therefore be more useful to It will therefore be more useful to focus on 1-month prevalence and defocus on 1-month prevalence and decompose information about duration. compose information about duration.
(b) (b) The duration of episodes has a logThe duration of episodes has a lognormal distribution. The best way to normal distribution. The best way to report this variable is through the use report this variable is through the use of medians, quartiles or logarithmic of medians, quartiles or logarithmic values. However, in the GBD project, values. However, in the GBD project, the arithmetic mean was used for the the arithmetic mean was used for the estimation of years of life with disability estimation of years of life with disability across all the conditions. So-called across all the conditions. So-called dysthymia and 'double depression' dysthymia and 'double depression' cases have extreme duration values cases have extreme duration values (i.e. longer than 2 years) and these (i.e. longer than 2 years) and these may drive the mean higher. On the may drive the mean higher. On the other hand, putting all long-term cases other hand, putting all long-term cases into a dysthymia category or excluding into a dysthymia category or excluding them is not appropriate: irrespective of them is not appropriate: irrespective of the diagnostic validity of dysthymia the diagnostic validity of dysthymia this manipulation creates a bias, this manipulation creates a bias, because the burden for depres because the burden for depression is sion is inappropriately lowered owing inappropriately lowered owing to the to the lower disability weight for dysthymia. lower disability weight for dysthymia. A better way of modelling is needed in A better way of modelling is needed in the next wave of GBD. the next wave of GBD.
(c) (c) It may be important to treat first It may be important to treat first episodes separately because it has been episodes separately because it has been consistently shown that first episodes consistently shown that first episodes last longer. This may be due to last longer. This may be due to delay in seeking help, which shows delay in seeking help, which shows a learn a learning curve enhancement for ing curve enhancement for recurrent episodes. recurrent episodes.
(d) (d) The analytical approach to duration
The analytical approach to duration needs some methodological innovations needs some methodological innovations in measurement and in charting the in measurement and in charting the course of episodes (e.g. Denicoff course of episodes (e.g. Denicoff et al et al, , 2002) . We also need to define sub-2002). We also need to define subthreshold states, because dichotomisathreshold states, because dichotomisation as case tion as case v v. no case is a crude way . no case is a crude way to analyse the course of illness. To to analyse the course of illness. To depict the temporal development of depict the temporal development of illness we need symptom profiles, funcillness we need symptom profiles, functioning data and adjustment factors as tioning data and adjustment factors as well as response to therapy. well as response to therapy.
The GBD study indicates that depresThe GBD study indicates that depression is the most disabling and burdensome sion is the most disabling and burdensome condition in the world. Paradoxically, we condition in the world. Paradoxically, we know little about the epidemiology of this know little about the epidemiology of this condition: age at first onset, duration and condition: age at first onset, duration and recurrence risk. Studying duration is the recurrence risk. Studying duration is the key to understanding how we can best key to understanding how we can best intervene during an episode; similarly, age intervene during an episode; similarly, age at onset may be a guide for primary prevenat onset may be a guide for primary prevention and recurrence risk for secondary tion and recurrence risk for secondary prevention. Already we know the basic prevention. Already we know the basic associations between gender and duration associations between gender and duration of depressive episodes. There is no differof depressive episodes. There is no difference between women and men in terms of ence between women and men in terms of duration or recurrence: the gender differduration or recurrence: the gender difference lies in the first occurrence of depresence lies in the first occurrence of depression. Women are more likely to become sion. Women are more likely to become depressed earlier in their lifetime. depressed earlier in their lifetime.
However, we know little about the However, we know little about the predictors of duration. We are ignorant of predictors of duration. We are ignorant of even basic information such as whether even basic information such as whether the poor have longer episodes than do the the poor have longer episodes than do the rich. By knowing the predictors of durarich. By knowing the predictors of duration, tion, we can possibly modify the recovery we can possibly modify the recovery process and interventions. Few studies on process and interventions. Few studies on predictors of duration exist; yet huge predictors of duration exist; yet huge resources are spent on treatment. As noted resources are spent on treatment. As noted by Spijker by Spijker et al et al, we do not even have good , we do not even have good epidemiological data on how and for how epidemiological data on how and for how long depressive episodes persist. It is neceslong depressive episodes persist. It is necessary to have prospective studies on the sary to have prospective studies on the distribution and predictors of duration both distribution and predictors of duration both in community and in clinical samples. in community and in clinical samples.
THE GLOBAL PICTURE THE GLOBAL PICTURE
These findings on the duration and epideThese findings on the duration and epidemiology of depressive disorders mainly miology of depressive disorders mainly relate to North America and Europe. To relate to North America and Europe. To understand the global burden of depressive understand the global burden of depressive disorders, taking into account the variadisorders, taking into account the variations in service provision and diffent poputions in service provision and diffent populations' mental health literacy, we still have lations' mental health literacy, we still have a long way to go. The data are scarce or a long way to go. The data are scarce or fragmented for many parts of the world. fragmented for many parts of the world. To address this issue, the WHO has inTo address this issue, the WHO has initiated a series of world mental health itiated a series of world mental health surveys, focusing on the epidemiology of surveys, focusing on the epidemiology of mental disorders within a general health mental disorders within a general health framework (Kessler & Ustun, 2000) . These framework (Kessler & Ü stü n, 2000) . These surveys will provide evidence for duration surveys will provide evidence for duration and other epidemiological indicators, enand other epidemiological indicators, enabling us to build better intervention stratabling us to build better intervention strategies to deal with the global burden of egies to deal with the global burden of depression. depression.
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